A small study found a significantly higher rate of transcription errors in women compared with men using a commercial voice recognition application. Causes of the discrepancy may include the differences in the volume and frequency of speech between sexes or more fundamental differences in how the application was tested at time of development.
A small study found a significantly higher rate of transcription errors in women compared with men using a commercial voice recognition application. Causes of the discrepancy may include the differences in the volume and frequency of speech between sexes or more fundamental differences in how the application was tested at time of development.
Dr. Syed Mahmood Ali, a radiology resident at the University of Maryland Medical Center, and colleagues trained five male and five female radiology residents on a speech recognition system. They asked each resident to dictate a standardized set of 10 radiology reports containing a total of 2123 words. The generated reports were compared with the original reports, and error rates were calculated. Researchers defined the error rate as the sum of the number of word insertions and deletions divided by the total word count for a given report.
Error rates in the male population ranged from 0.025 to 0.139, with a mean of 0.082. Error rates in the female population ranged from 0.015 to 0.206, with a mean of 0.100.
"These error rates may have significant negative impact on reporting accuracy and output, disproportionately affecting female radiologists," Ali reported at the American Roentgen Ray Society meeting.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.